Why Chinese investment is headed to European shores
Paul Aversano and Xuong Liu, managing directors of Alvarez & Marsal, comment on the impact of US/China trade tensions on cross-border M&A – specifically what it means for the UK.
China
Chinese broker to be the first Anbang asset under the hammer
In what would be the first of many expected disposals, the nationalised Chinese conglomerate Anbang Insurance Group has…
JPMorgan pioneers Chinese push
In the first of what may be a series of such initiatives by foreign banks, JPMorgan Chase has…
Anbang starts to unwind overseas acquisition spree
One of the most extensive disposal programmes that the world has seen for many years seems to have…
HNA continues deleveraging process
The extent of the refocusing of the strategy of the once highly acquisitive Chinese conglomerate HNA has again…
CR Beer in talks to buy Heineken’s China business
China Resources Beer is in talks about potentially purchasing Heineken’s business in China, a transaction that could be…
HNA turns away from M&A
China’s HNA Group is starting to reverse its acquisitive land-grab in response to concerns over its debt levels…
Pessina hopes for China panacea
Walgreens Boots Alliance CEO Stefano Pessina is hoping the company’s struggles in China will be over after making…
Chinese deal activity evolves, and the lull will be temporary
Although Chinese outbound M&A has been much slower in 2017 than it was in 2016, the long-term outlook…
Shanghai Pharma’s M&A appetite remains unsated
With the ink barely dry on its US$1.2bn agreement to acquire Cardinal Health’s Chinese distribution business, the head…
